Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Combined airway valve therapy in severe emphysema improves lung function and walking distance for patients with heterogeneous disease, despite some risks.
Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...
The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
1d
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic obstructive pulmonary disease (COPD). The Downtown Amarillo Library will be ...
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback